Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | CASP3 | P42574 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.67 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.67 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.67 |
| ▸ | ATG4B | Q9Y4P1 | 12/20 | 0.66 |
| ▸ | PLA2G1B | P04054 | 11/20 | 0.66 |
| ▸ | THRA | P10827 | 2/20 | 0.66 |
| ▸ | THRB | P10828 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.57 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3684326 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| SCHEMBL3025061 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| SCHEMBL6279557 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| SCHEMBL6287180 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| SCHEMBL6287182 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| SCHEMBL19460591 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| SCHEMBL6279559 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| SCHEMBL11765995 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| Hydrochloric Acid SCHEMBL11765635 | 0.98 | ALDH1A1 (0.66) | ALDH1A1KDM4ENPC1HPGDCASP3 | |
| Hydrochloric Acid SCHEMBL11612234 | 0.98 | ALDH1A1 (0.66) | ALDH1A1KDM4ENPC1HPGDCASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | DOW TORAY CO LTD (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4626941-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESSTHEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | Dow Toray Co., Ltd. (JP) | 2025-10-08 | — | — | EP | disclosed |
| US-20240225981-A1 | Synthesized Molecule of Solketal Esters from Palm Kit Oil and Glycerin for Cosmetic and Agricultural Formulations | NUOL GREEN CHEMISTRY LLC | 2024-07-11 | — | — | US | disclosed |
| WO-2024113195-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESSTHEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | DOW TORAY CO., LTD. (JP) | 2024-06-06 | — | — | WO | disclosed |
| EP-3257497-B1 | ANTIOXIDANT AGENT, ANTIOXIDANT COSMETIC AND UV CARE COSMETIC BASED ON ENZYMATICALLY SYNTHESIZED GLYCOGEN OR AN ALPHA-AMYLASE DIGEST THEREOF | EZAKI GLICO CO (JP) | 2024-04-24 | — | — | EP | disclosed |
| WO-2023106267-A1 | OIL-IN-WATER ULTRAVIOLET-PROTECTIVE COSMETIC | 岩瀬コスファ株式会社 | 2023-06-15 | — | — | WO | disclosed |
| WO-2022255352-A1 | DERMATOLOGICAL TOPICAL AGENT | 花王株式会社 | 2022-12-08 | — | — | WO | disclosed |
| US-20220339083-A1 | EMULSION COMPOSITION, COSMETIC COMPOSITION, AND METHOD FOR PREPARING EMULSION COMPOSITION | DAIO PAPER CORPORATION (JP) | 2022-10-27 | — | — | US | disclosed |
| EP-4039246-A1 | EMULSION COMPOSITION, COSMETIC COMPOSITION, AND METHOD FOR PRODUCING EMULSION COMPOSITION | Daio Paper Corporation (JP) | 2022-08-10 | — | — | EP | disclosed |
| WO-2022092284-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | 日産化学株式会社 | 2022-05-05 | — | — | WO | disclosed |
| US-5827507-A | MATRIX PARTICLES AND DAUGHTER PARTICLES OF DIFFERENT BAND GAP ENERGIES | KAO CORPORATION (JP) | 1998-10-27 | — | — | US | disclosed |
| EP-0721484-B1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | KAO CORP (JP) | 1998-06-17 | — | — | EP | disclosed |
| EP-0765656-A1 | Water-in-oil type emulsion cosmetic composition | SHISEIDO COMPANY LIMITED (JP) | 1997-04-02 | — | — | EP | disclosed |
| EP-0721484-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | Kao Corporation (JP) | 1996-07-17 | — | — | EP | disclosed |
| WO-1995009895-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | KAO CORPORATION (JP) | 1995-04-13 | — | — | WO | disclosed |
| EP-0123543-B1 | LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION AND USE AND COMPOSITIONS CONTAINING THEM | MERCK FROSST CANADA INC. (CA) | 1988-02-03 | — | — | EP | disclosed |
| US-4609744-A | 4-oxo-benzopyran carboxylic acids | MERCK FROSST CANADA INC. (CA) | 1986-09-02 | — | — | US | disclosed |
| EP-0123543-A1 | Leukotriene antagonists, their production and use and compositions containing them | MERCK FROSST CANADA INC. (CA) | 1984-10-31 | — | — | EP | disclosed |
| US-4061587-A | Liquid crystalline cinnamic acid esters | HOFFMANN-LA ROCHE INC. (US) | 1977-12-06 | — | — | US | disclosed |
| US-3975429-A | Cyclopropanemethyl esters of cinnamic acid and derivatives thereof | ZOECON CORPORATION (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | FOXM1, FOXK1, TAF1L | ALDH1A1 332/4885KDM4E 3029/4885NPC1 1821/4885 |
| US-20240225981-A1 | Synthesized Molecule of Solketal Esters from Palm Kit Oil and Glycerin for Cosmetic and Agricultural Formulations | DGKK, DGKA, DGKG | ALDH1A1 1773/4885KDM4E 2988/4885NPC1 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.